JP2019531764A5 - - Google Patents

Download PDF

Info

Publication number
JP2019531764A5
JP2019531764A5 JP2019537049A JP2019537049A JP2019531764A5 JP 2019531764 A5 JP2019531764 A5 JP 2019531764A5 JP 2019537049 A JP2019537049 A JP 2019537049A JP 2019537049 A JP2019537049 A JP 2019537049A JP 2019531764 A5 JP2019531764 A5 JP 2019531764A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
acid sequence
set forth
binding domain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019537049A
Other languages
English (en)
Japanese (ja)
Other versions
JP7224289B2 (ja
JP2019531764A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/052808 external-priority patent/WO2018057802A1/en
Publication of JP2019531764A publication Critical patent/JP2019531764A/ja
Publication of JP2019531764A5 publication Critical patent/JP2019531764A5/ja
Priority to JP2023016697A priority Critical patent/JP2023058573A/ja
Application granted granted Critical
Publication of JP7224289B2 publication Critical patent/JP7224289B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019537049A 2016-09-21 2017-09-21 Cd123結合タンパク質並びに関連する組成物及び方法 Active JP7224289B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023016697A JP2023058573A (ja) 2016-09-21 2023-02-07 Cd123結合タンパク質並びに関連する組成物及び方法

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662397736P 2016-09-21 2016-09-21
US62/397,736 2016-09-21
US201762466192P 2017-03-02 2017-03-02
US62/466,192 2017-03-02
PCT/US2017/052808 WO2018057802A1 (en) 2016-09-21 2017-09-21 Cd123 binding proteins and related compositions and methods

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023016697A Division JP2023058573A (ja) 2016-09-21 2023-02-07 Cd123結合タンパク質並びに関連する組成物及び方法

Publications (3)

Publication Number Publication Date
JP2019531764A JP2019531764A (ja) 2019-11-07
JP2019531764A5 true JP2019531764A5 (enExample) 2020-12-17
JP7224289B2 JP7224289B2 (ja) 2023-02-17

Family

ID=61690646

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019537049A Active JP7224289B2 (ja) 2016-09-21 2017-09-21 Cd123結合タンパク質並びに関連する組成物及び方法
JP2023016697A Pending JP2023058573A (ja) 2016-09-21 2023-02-07 Cd123結合タンパク質並びに関連する組成物及び方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023016697A Pending JP2023058573A (ja) 2016-09-21 2023-02-07 Cd123結合タンパク質並びに関連する組成物及び方法

Country Status (17)

Country Link
US (4) US11242400B2 (enExample)
EP (1) EP3515491A4 (enExample)
JP (2) JP7224289B2 (enExample)
KR (1) KR102559732B1 (enExample)
CN (1) CN109952112B (enExample)
AU (1) AU2017331256B2 (enExample)
BR (1) BR112019005333A2 (enExample)
CA (1) CA3037688A1 (enExample)
CO (1) CO2019003951A2 (enExample)
IL (1) IL265484B2 (enExample)
MX (2) MX2019003225A (enExample)
MY (1) MY194290A (enExample)
PH (1) PH12019500609B1 (enExample)
SG (1) SG10202102846SA (enExample)
UA (1) UA127450C2 (enExample)
WO (1) WO2018057802A1 (enExample)
ZA (1) ZA201902323B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA201891178A1 (ru) 2015-12-14 2019-01-31 Макродженикс, Инк. Биспецифичные молекулы, обладающие иммунореактивностью в отношении pd-1 и ctla-4, и способы их применения
US11242400B2 (en) 2016-09-21 2022-02-08 Aptevo Research And Development Llc CD123 binding proteins and related compositions and methods
AU2020269268A1 (en) 2019-05-04 2021-11-11 Inhibrx Biosciences, Inc. CD123-binding polypeptides and uses thereof
EP3753954A1 (en) * 2019-06-21 2020-12-23 Université de Franche-Comté Anti-cd123 antibodies, anti-cd123 chimeric antigen receptors and anti-cd123 chimeric antigen receptors t cells
AU2020329217A1 (en) * 2019-08-12 2022-07-28 Aptevo Research And Development Llc 4-1BB and OX40 binding proteins and related compositions and methods, antibodies against 4-1BB, antibodies against OX40
CN110804096B (zh) * 2019-11-21 2021-07-06 深圳普瑞金生物药业有限公司 Cd123单域抗体、核苷酸序列、表达载体及试剂盒
JP2023512446A (ja) * 2020-01-13 2023-03-27 アプティーボ リサーチ アンド デベロップメント エルエルシー 治療的タンパク質の薬物送達システム構成要素への吸着を防ぐ方法および組成物
WO2021146328A1 (en) * 2020-01-13 2021-07-22 Aptevo Research And Development Llc Formulations for protein therapeutics
CN111171155B (zh) * 2020-02-05 2021-02-19 北京智仁美博生物科技有限公司 抗cd3和cd123双特异性抗体及其用途
WO2021247892A1 (en) * 2020-06-04 2021-12-09 Amgen Inc. Assessment of cleaning procedures of a biotherapeutic manufacturing process
CN111732635B (zh) * 2020-06-22 2022-03-22 中国医学科学院基础医学研究所 与cd123蛋白特异性结合的多肽、多肽复合物、共递送系统及其制备方法与应用
US20230391856A1 (en) * 2020-10-23 2023-12-07 Icahn School Of Medicine At Mount Sinai Sars-cov-2 antibodies and uses thereof
US20240301086A1 (en) * 2020-12-01 2024-09-12 Aptevo Research And Development Llc Tumor-associated antigens and cd3-binding proteins, related compositions, and methods
MX2023009615A (es) * 2021-02-17 2023-08-24 Igm Biosciences Inc Moleculas de union anti-cd123 y usos de estas.
JP2024519964A (ja) * 2021-05-21 2024-05-21 アプティーボ リサーチ アンド デベロップメント エルエルシー タンパク質治療薬のための投薬レジメン
CN116162148B (zh) * 2021-11-24 2025-09-09 中山光度生物医药有限公司 多特异性配体结合分子及其应用
CN116836282B (zh) * 2023-02-13 2024-03-29 北京艺妙神州医药科技有限公司 抗体、嵌合抗原受体及其用途
CN117660325B (zh) * 2024-01-31 2024-04-19 苏州科为康生物医药科技有限公司 一种制备脐带血msc的培养基及其方法

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5530101A (en) * 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
EP0940468A1 (en) 1991-06-14 1999-09-08 Genentech, Inc. Humanized antibody variable domain
US5731168A (en) 1995-03-01 1998-03-24 Genentech, Inc. Method for making heteromultimeric polypeptides
US5834597A (en) * 1996-05-20 1998-11-10 Protein Design Labs, Inc. Mutated nonactivating IgG2 domains and anti CD3 antibodies incorporating the same
DK0826696T3 (da) 1996-09-03 2002-09-23 Gsf Forschungszentrum Umwelt Anvendelse af bi- og trispecifikke antistoffer til inducering af en tumorimmunitet
AU2002329647A1 (en) 2001-07-26 2003-02-24 University Of Utah Research Foundation In vitro assays for inhibitors of hiv capsid conformational changes and for hiv capsid formation
EP2332989B1 (en) 2002-05-22 2015-04-01 ESBATech, an Alcon Biomedical Research Unit LLC Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying same
US20050163782A1 (en) 2003-06-27 2005-07-28 Biogen Idec Ma Inc. Modified binding molecules comprising connecting peptides
EP1711527A4 (en) * 2003-12-15 2008-09-03 Dendreon Corp HLA-DR SPECIFIC ANTIBODIES, COMPOSITIONS AND METHODS
CA2595906C (en) 2005-02-01 2014-04-22 Dyax Corp. Libraries and methods for isolating antibodies
CA2608656A1 (en) * 2005-05-16 2006-11-23 Morphotek, Inc. Regulated vectors for selection of cells exhibiting desired phenotypes
CA2614640A1 (en) 2005-07-11 2007-01-18 Macrogenics, Inc. Methods for the treatment of autoimmune disorders using immunosuppressive monoclonal antibodies with reduced toxicity
US7612181B2 (en) 2005-08-19 2009-11-03 Abbott Laboratories Dual variable domain immunoglobulin and uses thereof
EP2418223A3 (en) 2006-06-12 2013-01-16 Emergent Product Development Seattle, LLC Single-chain multivalent binding proteins with effector function
US7949480B2 (en) 2006-06-14 2011-05-24 Simphotek, Inc. Method for determining an interaction between an electromagnetic radiation and a material
CA2664738C (en) 2006-09-29 2017-03-07 Oncomed Pharmaceuticals, Inc. Compositions and methods for diagnosing and treating cancer
WO2009017823A2 (en) 2007-08-01 2009-02-05 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health Of Human Services, National Institutes Of Health A fold-back diabody diphtheria toxin immunotoxin and methods of use
EP3106468A1 (en) * 2008-10-01 2016-12-21 Amgen Research (Munich) GmbH Cross-species-specific psmaxcd3 bispecific single chain antibody
PT2426148E (pt) 2009-04-27 2015-10-26 Kyowa Hakko Kirin Co Ltd Anticorpo anti-rá-il-3 para se utilizar no tratamento de tumores do sangue
US8758750B2 (en) 2009-09-15 2014-06-24 The Board Of Trustees Of The Leland Stanford Junior University Synergistic anti-CD47 therapy for hematologic cancers
SG181952A1 (en) 2009-12-29 2012-07-30 Emergent Product Dev Seattle Heterodimer binding proteins and uses thereof
NZ604510A (en) * 2010-08-17 2013-10-25 Csl Ltd Dilutable biocidal compositions and methods of use
UA112062C2 (uk) 2010-10-04 2016-07-25 Бьорінгер Інгельхайм Інтернаціональ Гмбх Cd33-зв'язувальний агент
EP2637692A4 (en) 2010-11-12 2014-09-10 Scott & White Healthcare ANTIBODIES TO THE ENDOTHELIAL TUMOR MARKER 8
US10202452B2 (en) * 2012-04-20 2019-02-12 Aptevo Research And Development Llc CD3 binding polypeptides
EP4053162A1 (en) * 2012-05-18 2022-09-07 Aptevo Research and Development LLC Bispecific scfv immunofusion (bif) binding to cd123 and cd3
WO2014143807A2 (en) * 2013-03-15 2014-09-18 Stromatt Scott Anti-cd37 antibody and bcr pathway antagonist combination therapy for treatment of b-cell malignancies and disorders
EP2839842A1 (en) * 2013-08-23 2015-02-25 MacroGenics, Inc. Bi-specific monovalent diabodies that are capable of binding CD123 and CD3 and uses thereof
JO3568B1 (ar) * 2014-09-05 2020-07-05 Janssen Pharmaceutica Nv عوامل ربط cd123 واستخداماتها
US10259887B2 (en) * 2014-11-26 2019-04-16 Xencor, Inc. Heterodimeric antibodies that bind CD3 and tumor antigens
WO2016094873A2 (en) 2014-12-12 2016-06-16 Emergent Product Development Seattle, Llc Receptor tyrosine kinase-like orphan receptor 1 binding proteins and related compositions and methods
TWI702229B (zh) 2014-12-19 2020-08-21 美商再生元醫藥公司 流行性感冒病毒血球凝集素之人類抗體
MY191964A (en) * 2015-01-23 2022-07-21 Sanofi Sa Anti-cd3 antibodies, anti-cd123 antibodies and bispecific antibodies specifically binding to cd3 and/or cd123
EP3256495A4 (en) 2015-02-11 2018-09-19 Aptevo Research and Development LLC Compositions and methods for combination therapy with prostate-specific membrane antigen binding proteins
MX2018003292A (es) 2015-09-21 2018-08-01 Aptevo Res & Development Llc Polipéptidos de unión a cd3.
WO2017210443A1 (en) 2016-06-01 2017-12-07 Xencor, Inc. Bispecific antibodies that bind cd123 and cd3
US11242400B2 (en) 2016-09-21 2022-02-08 Aptevo Research And Development Llc CD123 binding proteins and related compositions and methods
WO2021146328A1 (en) 2020-01-13 2021-07-22 Aptevo Research And Development Llc Formulations for protein therapeutics
JP2023512446A (ja) 2020-01-13 2023-03-27 アプティーボ リサーチ アンド デベロップメント エルエルシー 治療的タンパク質の薬物送達システム構成要素への吸着を防ぐ方法および組成物

Similar Documents

Publication Publication Date Title
JP2019531764A5 (enExample)
JP2023058573A5 (enExample)
JP2015533853A5 (enExample)
JP2018531000A5 (enExample)
IL276830B1 (en) Anti-claudin 18.2 antibodies and their uses
JP2016505556A5 (enExample)
JP2020501531A5 (enExample)
JP2017149720A5 (enExample)
JP2018519263A5 (enExample)
JP2017535257A5 (enExample)
JP2018510617A5 (enExample)
JP2018503380A5 (enExample)
JP2017506067A5 (enExample)
HK1215035A1 (zh) 人源化抗cd134(ox40)抗體及其應用
JP2016512223A5 (enExample)
JP2018513149A5 (enExample)
RU2014106671A (ru) Варианты гуманизированных иммуномодулирующих моноклональных антител
RU2017105915A (ru) Антитела против pd-1
JP2013545738A5 (enExample)
RU2013140433A (ru) Человеческие антитела и конъюгаты антитело-препарат против cd74
RU2013152960A (ru) Анти-cd40-антитела и способы применения
JP2013545455A5 (enExample)
JP2016539096A5 (enExample)
JP2020530770A5 (enExample)
IL272103B1 (en) Antigen binding proteins binding to 5T4 and 4-1BB and related compositions and methods of treating cancer